Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jenna who wrote (61395)	9/15/1999 2:55:00 PM
From: kha vu	Read Replies (1) of 120523

IMNX: complete analysis on technical, business and fundamental at moneycentral.msn.com <<<What does the company do? Immunex develops and manufactures biopharmaceutical products to treat cancer, autoimmune disorders, and infectious diseases. The company's primary approved products are Leukine, which is used to treat bone marrow transplant patients, and Novantrone, which is used to treat acute non-lymphocytic leukemia and to ease pain associated with prostate cancer. The FDA has approved Immunex's Enbrel, a rheumatoid arthritis treatment that has the potential to be a financial mother lode. Immunex is also developing drugs that treat asthma, leukemia, and certain cancers. Pharmaceutical research giant American Home Products owns 54% of Immunex. >>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next